Clinical Trials Directory

Trials / Terminated

TerminatedNCT04001335

Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in Belgium

Status
Terminated
Phase
Study type
Observational
Enrollment
6 (actual)
Sponsor
Institute of Tropical Medicine, Belgium · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Cutaneous Leishmaniasis (CL) is a neglected tropical disease which is increasingly seen in travelers and migrants evaluated in travel clinics of non-endemic countries. Various CL species are present in different parts of the world, and these different species vary in severity, prognosis and therapeutic approaches. At ITM, diagnosis of CL in suspected patients is done using a skin biopsy, analyzed by diagnostic PCR, and species typing PCR. This method is invasive, and diagnosis is often delayed for days to weeks. The new antigen-based CL Detect Rapid Test uses dental broach sampling and has results within 30 minutes. Dental broach samples left over from the Cl Detect Rapid test may still be used for PCR including species typing. How well the CL Detect Rapid Test performs in the varied population of a travel clinic and whether it is possible to use dental broach sampling for further PCR tests in this population needs to be evaluated The aim of this study is to study the performance of the CL Detect Rapid Test and whether dental broach sampling can replace skin biopsy for CL at ITM.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDental BroachDental broach, RDT and PCR

Timeline

Start date
2019-08-12
Primary completion
2021-03-01
Completion
2021-03-01
First posted
2019-06-28
Last updated
2021-03-04

Locations

1 site across 1 country: Belgium

Regulatory

Source: ClinicalTrials.gov record NCT04001335. Inclusion in this directory is not an endorsement.